The market is fueled by the technology’s ability to map biomolecules and cellular interactions within tissues, enabling precision diagnostics, early disease detection, and targeted treatment ...

Vizgen, Inc., a leader in spatial multi-omics at single-cell resolution, today announced a series of innovations under development to help accelerate drug discovery, advance understanding of disease ...

Chronic inflammation is both a driver and suppressor of cancer depending on context. Key players-NF-κB, IL-6, STAT3, TAMs, MDSCs, and Tregs-orchestrate a tumor-permissive microenvironment.

Department of Chemistry and Biochemistry, University of South Carolina, Columbia, United States ...

Risk prediction has been used in the primary prevention of cardiovascular disease for >3 decades. Contemporary cardiovascular risk assessment relies on multivariable models, which integrate ...

This study reports an important and novel finding that TENT5A, an enzyme involved in fine-tuning poly(A) tail length on selected mRNAs, is required for proper enamel mineralization in mice. The ...

Digital twins revolutionize drug discovery by integrating AI and biological data, enhancing prediction, trial design, and ...

Is the IDOL enzyme the key to stopping Alzheimer's? New research shows that blocking this single target can dissolve brain plaques and boost cognitive resilience.

Discover how researchers are overcoming the limitations of the undruggable target in drug discovery using novel approaches ...